logo
Select company
Select metric
$ 6.53MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
25
Sector
44
Industry
32
History
15
$ 0.53Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 6.53M
3/31/2025$ 10.87M
12/31/2024$ 7.59M
9/30/2024$ 4.62M
6/30/2024$ 5.82M
3/31/2024$ 1.15M
12/31/2023$ -4.77M
9/30/2023$ -8.66M
6/30/2023$ -12.98M
3/31/2023$ -14.4M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, PROPHASE LABS INC's average CF - Equity has been $ 6.78M.
  • The median CF - Equity for PROPHASE LABS INC during this period was $ 576.5K
  • PROPHASE LABS INC reached its highest CF - Equity over the past 5 years at $ 40.63M.
  • The lowest CF - Equity recorded by PROPHASE LABS INC in the same timeframe $ -14.4M

PROPHASE LABS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
BNBX : APPLIED DNA SCIENCES INC $ 7.54MINBS : INTELLIGENT BIO SOLUTIONS INC $ 4.6MTNON : TENON MEDICAL INC $ 16.39MTRAW : TRAWS PHARMA INC $ 23.37MTXMD : THERAPEUTICSMD INC $ 0LGVN : LONGEVERON INC $ 14MBOLT : BOLT BIOTHERAPEUTICS INC $ 43KLPCN : LIPOCINE INC $ 75.62KCYCN : CYCLERION THERAPEUTICS INC $ 1.38MXAIR : BEYOND AIR INC $ 23.82M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

PRPH - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -14.4M

Minimum

Mar 31, 2023

$ 40.63M

Maximum

Mar 31, 2021

$ 6.78M

Average

$ 576.5K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 98.02K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 98.02K
median$ 0
std$ 17.64M